0

Close
 
Upcoming Allied Market Research
2023
Adhesion Barrier Market

Adhesion Barrier Market: Global Opportunity Analysis and Industry Forecast 2019-2026 Market

LS : Pharmaceuticals
Report Code: A09554
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Adhesion Barrier Market

Request Now !

Adhesion barrier is a medical implant which can be used to minimize various abnormal internal scarring or adhesions after the surgery by separating the internal tissues and organs while are getting cured.Adhesion Barrier Market

According to surgeons, the proper surgical technique is very important to reduce any adhesion formation during the surgery and the treatment. From the past one century, many drugs and other substances like animal membranes, gold foil, sheets made of rubber, and Teflon, mineral oil have been used as adjuvant which help in reducing the risk of adhesion formation. Adhesions appear after abdominal and pelvic surgery, which are unavoidable. An adhesion leads to a significant post-surgical morbidity, infertility, bowel obstruction, and chronic pelvic pain or chronic abdominal pain. Surgeons sometimes also apply adhesion barriers while performing abdominal and pelvic surgery to avoid any impediments further.

Market scope and structure analysis:

COVID-19 scenario analysis:

To take care of the infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With a rise in the number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both healthcare professionals and civil populations for precautionary measures. Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. 

Owing to such factors, COVID 19 is expected to have a significant impact on the Adhesion barrier market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Increase in the knowledge and understanding of adhesions and the issues related to it, various surgical associations and hospitals have been increasing their focus towards  the awareness with respect to post-surgical adhesion formations and the availability of  anti-adhesive products to control these complications of the patients. These factors are responsible for the swift growth of the adhesion barrier market.

The International Adhesions Society has been providing information about the disorders related to adhesion and its treatment along with precautions which are taken by the patients, surgeons, and other healthcare professionals. IAS is also supporting patients and promotions of various researches for the prevention and treatment of adhesion disorders. These steps taken by IAS will surely increase the awareness and importance of anti-adhesion products in surgical procedures. Additionally, disorders of adhesion and their awareness is also increasing in Asia Pacific countries  and  is expected to further drive the demand for anti-adhesion products.

Most of the adhesions occur in after the surgical procedures are completed like gynecological, abdominal or pelvic, cardiac surgeries, neurosurgeries, and orthopedic surgeries and so on.

Although surgeons are well-aware of the risks and precaution to be taken for adhesion, they are not willing to use adhesion barriers due to the lack of reliable clinical evidence that supports the safety and efficacy of commercial adhesion barrier products. Moreover, the issues regarding the safety and effectiveness of adhesion barriers the manufacturing companies find it difficult to get marketing approvals for their products from the FDA. In the past few years, the market has also witnessed the discontinuation of many approved adhesion barrier products due to below-par clinical outcomes.

New product launches to flourish the market:

On March 28, 2019, FzioMed enrolled a patient in a clinical study to supports its new gel, Oxiplex which is an adhesive barrier gel to prove the effectiveness and safety of the gel. Oxiplex is an absorbable, synthetic viscoelastic gel that is applied after partial discectomy, to reduce postoperative leg pain, back pain, and neurologic symptoms.

Surge in usage in hospital applications:

Various surgical associations and hospitals are focusing to increase the awareness amongst the population about post-surgical adhesion formation and the available anti-adhesive products to control these complications.

Along with them, IAS is also working to increase the awareness and consumption among the patient and surgeons of adhesion barrier application post-surgery.

Key benefits of the report:

  • This study presents the analytical depiction of the global Adhesion barrier industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Adhesion barrier market share.
  • The current market is quantitatively analyzed to highlight the global Adhesion barrier market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Adhesion barrier market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Adhesion barrier Market research report:

  • What are the leading market players active in the Adhesion barrier market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

 Adhesion Barrier Market: Global Opportunity Analysis and Industry Forecast 2019–2026 Report Highlights

Aspects Details
By Product
  • Synthetic Adhesion Barriers
    • Hyaluronic Acid
    • Regenerated Cellulose
    • Polyethylene Glycol
  • Natural Adhesion Barriers
    • Collagen and Protein
    • Fibrin
By Application
  • Gynecological Surgeries
  • General/Abdominal Surgeries
  • Orthopedic Surgeries
  • Cardiovascular Surgeries
  • Neurological Surgeries
  • Urological Surgeries
  • Reconstructive Surgeries
  • Others
By Formulation
  • Film Formulations
  • Gel Formulations
  • Liquid Formulations
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players FzioMed, C.R. Bard, Anika Therapeutics, Atrium Medical Corporation, Integra LifeSciences, Sanofi, Innocoll Holdings, MAST Biosurgery, Johnson & Johnson, Baxter International
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: ADHESION BARRIER MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Synthetic Adhesion Barriers

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Hyaluronic Acid

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Regenerated Cellulose

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Polyethylene Glycol

        • 4.2.4.1. Market Size and Forecast

    • 4.3. Natural Adhesion Barriers

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Collagen and Protein

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Fibrin

        • 4.3.4.1. Market Size and Forecast

  • CHAPTER 5: ADHESION BARRIER MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Gynecological Surgeries

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. General/Abdominal Surgeries

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Orthopedic Surgeries

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Cardiovascular Surgeries

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Neurological Surgeries

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Urological Surgeries

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Reconstructive Surgeries

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

    • 5.9. Others

      • 5.9.1. Key Market Trends, Growth Factors and Opportunities

      • 5.9.2. Market Size and Forecast, By Region

      • 5.9.3. Market Share Analysis, By Country

  • CHAPTER 6: ADHESION BARRIER MARKET, BY FORMULATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Formulation

    • 6.2. Film Formulations

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Gel Formulations

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Liquid Formulations

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: ADHESION BARRIER MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By Formulation

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Adhesion Barrier Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By Formulation

      • 7.2.7. Canada Adhesion Barrier Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By Formulation

      • 7.2.8. Mexico Adhesion Barrier Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By Formulation

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By Formulation

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Adhesion Barrier Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By Formulation

      • 7.3.7. Germany Adhesion Barrier Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By Formulation

      • 7.3.8. Italy Adhesion Barrier Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By Formulation

      • 7.3.9. Spain Adhesion Barrier Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By Formulation

      • 7.3.10. UK Adhesion Barrier Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By Formulation

      • 7.3.11. Russia Adhesion Barrier Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By Formulation

      • 7.3.12. Rest Of Europe Adhesion Barrier Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By Formulation

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By Formulation

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Adhesion Barrier Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By Formulation

      • 7.4.7. Japan Adhesion Barrier Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By Formulation

      • 7.4.8. India Adhesion Barrier Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By Formulation

      • 7.4.9. South Korea Adhesion Barrier Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By Formulation

      • 7.4.10. Australia Adhesion Barrier Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By Formulation

      • 7.4.11. Thailand Adhesion Barrier Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By Formulation

      • 7.4.12. Malaysia Adhesion Barrier Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By Formulation

      • 7.4.13. Indonesia Adhesion Barrier Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By Formulation

      • 7.4.14. Rest of Asia Pacific Adhesion Barrier Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By Formulation

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By Formulation

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Adhesion Barrier Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By Formulation

      • 7.5.7. South Africa Adhesion Barrier Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By Formulation

      • 7.5.8. Saudi Arabia Adhesion Barrier Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By Formulation

      • 7.5.9. UAE Adhesion Barrier Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By Formulation

      • 7.5.10. Argentina Adhesion Barrier Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By Formulation

      • 7.5.11. Rest of LAMEA Adhesion Barrier Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By Formulation

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Johnson And Johnson

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Sanofi

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Baxter International

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. C.R. Bard

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Integra LifeSciences

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Anika Therapeutics

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Atrium Medical Corporation

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. FzioMed

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. MAST Biosurgery

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Innocoll Holdings

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ADHESION BARRIER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL ADHESION BARRIER MARKET FOR NATURAL ADHESION BARRIERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL ADHESION BARRIER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL ADHESION BARRIER MARKET FOR GYNECOLOGICAL SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL ADHESION BARRIER MARKET FOR GENERAL/ABDOMINAL SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL ADHESION BARRIER MARKET FOR ORTHOPEDIC SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL ADHESION BARRIER MARKET FOR CARDIOVASCULAR SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL ADHESION BARRIER MARKET FOR NEUROLOGICAL SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ADHESION BARRIER MARKET FOR UROLOGICAL SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL ADHESION BARRIER MARKET FOR RECONSTRUCTIVE SURGERIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL ADHESION BARRIER MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL ADHESION BARRIER MARKET, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL ADHESION BARRIER MARKET FOR FILM FORMULATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL ADHESION BARRIER MARKET FOR GEL FORMULATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL ADHESION BARRIER MARKET FOR LIQUID FORMULATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL ADHESION BARRIER MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA ADHESION BARRIER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 22. U.S. ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 23. U.S. ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. U.S. ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 25. CANADA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 26. CANADA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. CANADA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE ADHESION BARRIER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. GERMANY ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. GERMANY ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 41. ITALY ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 42. ITALY ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. ITALY ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 47. UK ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 48. UK ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. UK ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 50. RUSSIA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 51. RUSSIA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. RUSSIA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 53. REST OF EUROPE ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. REST OF EUROPE ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. REST OF EUROPE ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC ADHESION BARRIER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 58. ASIA-PACIFIC ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. ASIA-PACIFIC ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 60. CHINA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 61. CHINA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. CHINA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 63. JAPAN ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. JAPAN ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. JAPAN ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 66. INDIA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 67. INDIA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. INDIA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. SOUTH KOREA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 72. AUSTRALIA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 73. AUSTRALIA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. AUSTRALIA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 75. THAILAND ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 76. THAILAND ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. THAILAND ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 78. MALAYSIA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 79. MALAYSIA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 80. MALAYSIA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 81. INDONESIA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 82. INDONESIA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. INDONESIA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. REST OF ASIA PACIFIC ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 87. LAMEA ADHESION BARRIER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 88. LAMEA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 89. LAMEA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 90. LAMEA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 91. BRAZIL ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 92. BRAZIL ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 93. BRAZIL ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 95. SOUTH AFRICA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 96. SOUTH AFRICA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 97. SAUDI ARABIA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 98. SAUDI ARABIA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 99. SAUDI ARABIA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 100. UAE ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 101. UAE ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 102. UAE ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 103. ARGENTINA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 104. ARGENTINA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 105. ARGENTINA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 106. REST OF LAMEA ADHESION BARRIER, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 107. REST OF LAMEA ADHESION BARRIER, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 108. REST OF LAMEA ADHESION BARRIER, BY FORMULATION, 2022-2032 ($MILLION)
  • TABLE 109. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 110. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 111. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 112. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 113. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. SANOFI: KEY EXECUTIVES
  • TABLE 115. SANOFI: COMPANY SNAPSHOT
  • TABLE 116. SANOFI: OPERATING SEGMENTS
  • TABLE 117. SANOFI: PRODUCT PORTFOLIO
  • TABLE 118. SANOFI: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. BAXTER INTERNATIONAL: KEY EXECUTIVES
  • TABLE 120. BAXTER INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 121. BAXTER INTERNATIONAL: OPERATING SEGMENTS
  • TABLE 122. BAXTER INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 123. BAXTER INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. C.R. BARD: KEY EXECUTIVES
  • TABLE 125. C.R. BARD: COMPANY SNAPSHOT
  • TABLE 126. C.R. BARD: OPERATING SEGMENTS
  • TABLE 127. C.R. BARD: PRODUCT PORTFOLIO
  • TABLE 128. C.R. BARD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. INTEGRA LIFESCIENCES: KEY EXECUTIVES
  • TABLE 130. INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
  • TABLE 131. INTEGRA LIFESCIENCES: OPERATING SEGMENTS
  • TABLE 132. INTEGRA LIFESCIENCES: PRODUCT PORTFOLIO
  • TABLE 133. INTEGRA LIFESCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. ANIKA THERAPEUTICS: KEY EXECUTIVES
  • TABLE 135. ANIKA THERAPEUTICS: COMPANY SNAPSHOT
  • TABLE 136. ANIKA THERAPEUTICS: OPERATING SEGMENTS
  • TABLE 137. ANIKA THERAPEUTICS: PRODUCT PORTFOLIO
  • TABLE 138. ANIKA THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. ATRIUM MEDICAL CORPORATION: KEY EXECUTIVES
  • TABLE 140. ATRIUM MEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 141. ATRIUM MEDICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 142. ATRIUM MEDICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 143. ATRIUM MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. FZIOMED: KEY EXECUTIVES
  • TABLE 145. FZIOMED: COMPANY SNAPSHOT
  • TABLE 146. FZIOMED: OPERATING SEGMENTS
  • TABLE 147. FZIOMED: PRODUCT PORTFOLIO
  • TABLE 148. FZIOMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. MAST BIOSURGERY: KEY EXECUTIVES
  • TABLE 150. MAST BIOSURGERY: COMPANY SNAPSHOT
  • TABLE 151. MAST BIOSURGERY: OPERATING SEGMENTS
  • TABLE 152. MAST BIOSURGERY: PRODUCT PORTFOLIO
  • TABLE 153. MAST BIOSURGERY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. INNOCOLL HOLDINGS: KEY EXECUTIVES
  • TABLE 155. INNOCOLL HOLDINGS: COMPANY SNAPSHOT
  • TABLE 156. INNOCOLL HOLDINGS: OPERATING SEGMENTS
  • TABLE 157. INNOCOLL HOLDINGS: PRODUCT PORTFOLIO
  • TABLE 158. INNOCOLL HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ADHESION BARRIER MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ADHESION BARRIER MARKET
  • FIGURE 3. SEGMENTATION ADHESION BARRIER MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ADHESION BARRIER MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALADHESION BARRIER MARKET
  • FIGURE 11. ADHESION BARRIER MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. ADHESION BARRIER MARKET FOR NATURAL ADHESION BARRIERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. ADHESION BARRIER MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 15. ADHESION BARRIER MARKET FOR GYNECOLOGICAL SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. ADHESION BARRIER MARKET FOR GENERAL/ABDOMINAL SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. ADHESION BARRIER MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. ADHESION BARRIER MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. ADHESION BARRIER MARKET FOR NEUROLOGICAL SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. ADHESION BARRIER MARKET FOR UROLOGICAL SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. ADHESION BARRIER MARKET FOR RECONSTRUCTIVE SURGERIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. ADHESION BARRIER MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. ADHESION BARRIER MARKET SEGMENTATION, BY BY FORMULATION
  • FIGURE 24. ADHESION BARRIER MARKET FOR FILM FORMULATIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. ADHESION BARRIER MARKET FOR GEL FORMULATIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. ADHESION BARRIER MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 28. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 29. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 30. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 31. COMPETITIVE DASHBOARD
  • FIGURE 32. COMPETITIVE HEATMAP: ADHESION BARRIER MARKET
  • FIGURE 33. Top player positioning, 2022
  • FIGURE 34. JOHNSON AND JOHNSON: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. SANOFI: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. SANOFI: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. SANOFI: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. BAXTER INTERNATIONAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. BAXTER INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. BAXTER INTERNATIONAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. C.R. BARD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. C.R. BARD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. C.R. BARD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. INTEGRA LIFESCIENCES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. INTEGRA LIFESCIENCES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. INTEGRA LIFESCIENCES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. ANIKA THERAPEUTICS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. ANIKA THERAPEUTICS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. ANIKA THERAPEUTICS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. ATRIUM MEDICAL CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. ATRIUM MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. ATRIUM MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. FZIOMED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. FZIOMED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. FZIOMED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. MAST BIOSURGERY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. MAST BIOSURGERY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. MAST BIOSURGERY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 61. INNOCOLL HOLDINGS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 62. INNOCOLL HOLDINGS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 63. INNOCOLL HOLDINGS: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Adhesion Barrier Market

Start reading.
This Report and over 66,966+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers